BioSpace News Archive

Wilmington, Delaware, United States, Transparency Market Research Inc.: Dental biomaterials are biological or synthetic products typically used for the restoration of tooh supporting structures such as bones and soft tissues and periodontal structures in dentistry.

Wilmington, Delaware, United States, Transparency Market Research Inc.: The global cranial implants market is expanding due to an increase in the number of brain cancer and trauma cases and rapid technological advancements for establishing effective and efficient treatment platforms for cranial reconstruction.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Cogan’s syndrome is a rare autoimmune disorder.

Wilmington, Delaware, United States, Transparency Market Research Inc.: The global cartilage repair market is expected to rise due to breakthroughs in cartilage regeneration, an increase in the frequency of bone ailments like arthritis, and an ageing population.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Companies investing in bronchitis treatment market are interested in studying the etiology of bronchitis.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Patients suffering from idiopathic hyperhidrosis experience extreme sweating of the axilla, soles, palms, or face.

Anthos Therapeutics announced that the U.S. Food and Drug Administration has granted Fast Track Designation to its investigational Factor XI inhibitor, abelacimab, for the treatment of thrombosis associated with cancer.

Hansa Biopharma AB, “Hansa”, pioneer in enzyme technology for rare immunological conditions, announces that the first patient has been treated in the PAES for Idefirix® as a desensitization treatment for highly sensitized people undergoing a kidney transplant.

Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, is proud to announce the release of the MobileDaRt Evolution MX8 Version V type.

Sosei Group Corporation will announce its earnings results and present operational highlights for the 6 months ended 30 June 2022 on Wednesday, 10 August 2022.